PGAP6 and synucleinopathy: Hemizygous M83 mice (M83+/-) do not spontaneously develop a synucleinopathy up to 600 days of age, but develop progressive signs of motor dysfunction accompanied by cerebral deposition of aggregated and phosphorylated α-syn if injected with a pre-existing source of α-syn aggregates [26, 27, 31].